1. Isolation of a spirolactone norditerpenoid as a yeast Ca 2+ signal transduction inhibitor from Kuji amber and evaluation of its effects on PPM1A activity.
- Author
-
Shimizu E, Koshino H, Noro A, Maruyama M, Shimoda N, Uesugi S, Ohnishi M, and Kimura KI
- Subjects
- Animals, Cell Degranulation drug effects, Cell Line, Tumor, Diterpenes isolation & purification, Japan, Mast Cells drug effects, Molecular Structure, Rats, Spironolactone isolation & purification, Amber chemistry, Diterpenes pharmacology, Saccharomyces cerevisiae drug effects, Signal Transduction drug effects, Spironolactone pharmacology
- Abstract
A different type of biologically active compound from Kuji amber (Late Cretaceous, Japan) before the K-Pg boundary [65 million years ago (Ma)] was isolated based on the growth-restoring activity of a mutant yeast involving Ca
2+ signal transduction. It was identified as a spirolactone norditerpenoid, (4R*, 5S*, 8R*, 9R*, 10S*)-14,15,16,19-tetranor-labdan-13,9-olide (1) from spectral analyses with high-resolution electron ionization mass spectrometry (HREIMS), 1D and 2D nuclear magnetic resonance (NMR). Although the planar structure of 1 is known as an artificial derivative from marrubiin, it was isolated as a natural product from Kuji amber and its structure was elucidated for the first time. It had a growth-restoring activity against the mutant yeast through the direct or indirect inhibition of calcineurin activity [protein phosphatase, Mg2+ /Mn2+ -dependent 1A (PPM1A) activation]. Furthermore, the compound had potent inhibitory effect against the degranulation of rat basophilic leukemia 2H3 (RBL-2H3) cells., (Copyright © 2019 Elsevier B.V. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF